We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Evidence-Based Dermatology: Research Commentary |

A Randomized Controlled Trial of the Addition of Mycophenolate Mofetil or Placebo to Oral Corticosteroids in the Treatment of Pemphigus Vulgaris Fails to Demonstrate a Significant Difference in the Primary Outcome or Quality of Life

Michael Bigby, MD
Arch Dermatol. 2011;147(4):489-491. doi:10.1001/archdermatol.2011.56.
Text Size: A A A
Published online


Bigby  MStern  RSBigby  JA An evaluation of method reporting and use in clinical trials in dermatology. Arch Dermatol 1985;121 (11) 1394- 13994051526
Jüni  PAltman  DGEgger  M Systematic reviews in health care: assessing the quality of controlled clinical trials. BMJ 2001;323 (7303) 42- 4611440947
 Critical appraisal for therapy. http://www.cebm.net/index.aspx?o=109721 March2011;
Boutron  IDutton  SRavaud  PAltman  DG Reporting and interpretation of randomized controlled trials with statistically nonsignificant results for primary outcomes. JAMA 2010;303 (20) 2058- 206420501928
Beissert  SWerfel  TFrieling  U  et al.  A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of pemphigus. Arch Dermatol 2006;142 (11) 1447- 145417116835
Chams-Davatchi  CEsmaili  NDaneshpazhooh  M  et al.  Randomized controlled open-label trial of four treatment regimens for pemphigus vulgaris. J Am Acad Dermatol 2007;57 (4) 622- 62817583373
Martin  LKWerth  VVillanueva  ESegall  JMurrell  DFMurrell  DF Interventions for pemphigus vulgaris and pemphigus foliaceus. Cochrane Database Syst Rev 2009; (1) CD0062631916027210.1002/14651858.CD006263.pub2

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview





Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

1 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections